Literature DB >> 15285334

Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.

Calum R Park1, Dale L Munday.   

Abstract

Some naturally occurring biocompatible materials were evaluated as mucoadhesive controlled release excipients for buccal drug delivery. A range of tablets were prepared containing 0-50% w/w xanthan gum, karaya gum, guar gum, and glycol chitosan and were tested for swelling, drug release, and mucoadhesion. Guar gum was a poor mucoadhesive and lacked sufficient physical integrity for buccal delivery. Karaya gum demonstrated superior adhesion to guar gum and was able to provide zero-order drug release, but concentrations greater than 50% w/w may be required to provide suitable sustained release. Xanthan gum showed strong adhesion to the mucosal membrane and the 50% w/w formulation produced zero-order drug release over 4 hours, about the normal time interval between daily meals. Glycol chitosan produced the strongest adhesion, but concentrations greater than 50% w/w are required to produce a nonerodible matrix that can control drug release for over 4 hours. Swelling properties of the tablets were found to be a valuable indicator of the ability of the material to produce sustained release. Swelling studies also gave an indication of the adhesion values of the gum material where adhesion was solely dependent upon penetration of the polymer chains into the mucus layer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285334     DOI: 10.1081/ddc-120037492

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

1.  Comparative evaluation of porous versus nonporous mucoadhesive films as buccal delivery system of glibenclamide.

Authors:  Ajay Kumar; Vikas Bali; Manish Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2013-08-30       Impact factor: 3.246

2.  Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine.

Authors:  Rana Abu-Huwaij; Rana M Obaidat; Kamal Sweidan; Yusuf Al-Hiari
Journal:  AAPS PharmSciTech       Date:  2010-12-15       Impact factor: 3.246

3.  Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.

Authors:  Nisreen Hassan; R K Khar; Mushir Ali; Javed Ali
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

4.  Physicochemical Characterization of Grewia ferruginea Hochst. ex A. Rich Mucilage for Potential Use as a Pharmaceutical Excipient.

Authors:  Tsadkan Gebremeskel Haile; Gereziher Gebremedhin Sibhat; Fantahun Molla
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.411

Review 5.  Cashew Gum: A Review of Brazilian Patents and Pharmaceutical Applications with a Special Focus on Nanoparticles.

Authors:  Ricardo G Amaral; Lucas R Melo de Andrade; Luciana N Andrade; Kahynna C Loureiro; Eliana B Souto; Patrícia Severino
Journal:  Micromachines (Basel)       Date:  2022-07-18       Impact factor: 3.523

6.  Poloxamer-Based Hydrogel as Drug Delivery System: How Polymeric Excipients Influence the Chemical-Physical Properties.

Authors:  Elisa Brambilla; Silvia Locarno; Salvatore Gallo; Francesco Orsini; Carolina Pini; Marco Farronato; Douglas Vieira Thomaz; Cristina Lenardi; Marco Piazzoni; Gianluca Tartaglia
Journal:  Polymers (Basel)       Date:  2022-09-01       Impact factor: 4.967

7.  Herbal excipients in novel drug delivery systems.

Authors:  A Shirwaikar; Annie Shirwaikar; S Lakshmana Prabu; G Aravind Kumar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

8.  Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol.

Authors:  Amanpreet Kaur; Gurpreet Kaur
Journal:  Saudi Pharm J       Date:  2011-04-30       Impact factor: 4.330

9.  Effect of polymer type on characteristics of buccal tablets using factorial design.

Authors:  O Esim; A Savaser; C K Ozkan; Z Bayrak; C Tas; Y Ozkan
Journal:  Saudi Pharm J       Date:  2017-10-26       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.